Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-04-12 Purchase | 2023-04-12 7:05 pm | Viridian Therapeutics Inc. | VRDN | Myers Scott Dunseth Chief Executive Officer | 4,000 | $25.37 | $101,479 | 259,500 (Direct) | View |
| 2023-03-13 Purchase | 2023-03-13 4:06 pm | Viridian Therapeutics Inc. | VRDN | Myers Scott Dunseth Chief Executive Officer | 5,500 | $29.15 | $160,324 | 255,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-13 Option Award | 2024-11-13 5:46 pm | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Myers Scott Dunseth Director | 260,192 | $0 | 260,192 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-28 8:32 pm | N/A 2031-05-22 | DYNAVAX TECHNOLOGIES CORP | DVAX | Myers Scott Dunseth Director | 27,857 | $0 | 47,946 (Direct) | View |
| 2024-03-11 Disposition | 2024-03-11 5:24 pm | N/A N/A | Harpoon Therapeutics Inc. | HARP | Myers Scott Dunseth Director | 29,298 | $0 | 0 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 4:30 pm | N/A N/A | Harpoon Therapeutics Inc. | HARP | Myers Scott Dunseth Director | 2,048 | $0 | 22,666 (Direct) | View |
| 2023-11-27 Option Award | 2023-11-28 4:26 pm | N/A N/A | Harpoon Therapeutics Inc. | HARP | Myers Scott Dunseth Director | 5,000 | $0 | 20,618 (Direct) | View |
| 2023-11-13 Disposition | 2023-11-15 5:16 pm | N/A 2033-01-01 | Cartesian Therapeutics Inc. | RNAC | Myers Scott Dunseth Director | 87,500 | $0.93 | 0 (Direct) | View |
| 2023-11-13 Disposition | 2023-11-15 5:16 pm | N/A 2029-06-13 | Cartesian Therapeutics Inc. | RNAC | Myers Scott Dunseth Director | 120,000 | $0 | 0 (Direct) | View |
| 2023-10-01 Option Award | 2023-10-02 5:36 pm | N/A N/A | Harpoon Therapeutics Inc. | HARP | Myers Scott Dunseth Director | 5,797 | $0 | 15,618 (Direct) | View |
| 2023-07-01 Option Award | 2023-07-06 6:34 pm | N/A N/A | Harpoon Therapeutics Inc. | HARP | Myers Scott Dunseth Director | 35,634 | $0 | 98,215 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-23 4:36 pm | N/A 2033-06-21 | Harpoon Therapeutics Inc. | HARP | Myers Scott Dunseth Director | 46,000 | $0 | 46,000 (Direct) | View |
| 2023-05-26 Option Award | 2023-05-31 5:35 pm | N/A 2030-05-25 | DYNAVAX TECHNOLOGIES CORP | DVAX | Myers Scott Dunseth Director | 27,857 | $0 | 42,589 (Direct) | View |
| 2023-04-01 Option Award | 2023-04-04 5:06 pm | N/A N/A | Harpoon Therapeutics Inc. | HARP | Myers Scott Dunseth Director | 34,925 | $0 | 62,581 (Direct) | View |
| 2023-02-06 Option Award | 2023-02-07 6:55 pm | N/A 2033-02-06 | Viridian Therapeutics Inc. | VRDN | Myers Scott Dunseth Chief Executive Officer | 1,250,000 | $0 | 1,250,000 (Direct) | View |
| 2023-01-02 Option Award | 2023-01-04 5:06 pm | N/A 2033-01-01 | SELECTA BIOSCIENCES INC | SELB | Myers Scott Dunseth Director | 87,500 | $0 | 87,500 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 6:48 pm | N/A 2032-06-21 | Harpoon Therapeutics Inc. | HARP | Myers Scott Dunseth Director | 20,334 | $0 | 20,334 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-27 5:01 pm | N/A N/A | DYNAVAX TECHNOLOGIES CORP | DVAX | Myers Scott Dunseth Director | 20,893 | $0 | 20,893 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 4:34 pm | N/A 2032-01-02 | SELECTA BIOSCIENCES INC | SELB | Myers Scott Dunseth Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-11-17 Disposition | 2021-11-19 1:33 pm | N/A 2031-05-03 | Trillium Therapeutics Inc. | TRIL | Myers Scott Dunseth Director | 67,000 | $0 | 0 (Direct) | View |
| 2021-10-25 Option Award | 2021-10-26 4:22 pm | N/A 2031-10-25 | Harpoon Therapeutics Inc. | HARP | Myers Scott Dunseth Director | 10,167 | $0 | 10,167 (Direct) | View |
| 2021-10-19 Option Award | 2021-10-21 5:04 pm | N/A N/A | DYNAVAX TECHNOLOGIES CORP | DVAX | Myers Scott Dunseth Director | 55,714 | $0 | 55,714 (Direct) | View |
Ownership | 2021-10-21 5:03 pm | N/A N/A | DYNAVAX TECHNOLOGIES CORP | DVAX | Myers Scott Dunseth Director | 0 | $0 | 0 (Direct) | View |
| 2021-05-04 Option Award(A) | 2021-05-14 8:03 pm | N/A 2031-05-03 | Harpoon Therapeutics Inc. | HARP | Myers Scott Dunseth Director | 10,167 | $0 | 10,167 (Direct) | View |
| 2021-05-04 Option Award | 2021-05-07 9:56 pm | N/A 2031-05-03 | Harpoon Therapeutics Inc. | HARP | Myers Scott Dunseth Director | 10,167 | $0 | 10,167 (Direct) | View |
| 2021-05-03 Option Award | 2021-05-05 4:16 pm | N/A 2031-05-03 | Trillium Therapeutics Inc. | TRIL | Myers Scott Dunseth Director | 67,000 | $0 | 67,000 (Direct) | View |
| 2021-03-30 Option Award | 2021-04-01 6:31 pm | N/A 2031-03-29 | SELECTA BIOSCIENCES INC | SELB | Myers Scott Dunseth Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2020-11-16 Disposition | 2020-11-17 3:42 pm | N/A N/A | AMAG PHARMACEUTICALS INC. | AMAG | Myers Scott Dunseth President & CEO | 1,000,000 | $0 | 0 (Direct) | View |
| 2020-06-19 Option Award | 2020-06-23 4:47 pm | N/A 2030-06-18 | SELECTA BIOSCIENCES INC | SELB | Myers Scott Dunseth Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-05-28 Option Award | 2020-06-01 9:50 pm | N/A 2030-05-27 | Harpoon Therapeutics Inc. | HARP | Myers Scott Dunseth Director | 10,167 | $0 | 10,167 (Direct) | View |
| 2020-04-28 Option Award | 2020-04-30 5:02 pm | N/A 2030-04-28 | AMAG PHARMACEUTICALS INC. | AMAG | Myers Scott Dunseth President & CEO | 1,000,000 | $0 | 1,000,000 (Direct) | View |
| 2019-12-23 Option Award | 2019-12-26 5:29 pm | N/A N/A | SELECTA BIOSCIENCES INC | SELB | Myers Scott Dunseth Director | 39,409 | $1.46 | 100,549 (Direct) | View |
| 2019-12-23 Option Award | 2019-12-26 5:29 pm | 2019-12-23 2024-12-23 | SELECTA BIOSCIENCES INC | SELB | Myers Scott Dunseth Director | 19,704 | $0.125 | 100,549 (Direct) | View |